# Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)

> **NCT00920023** · PHASE4 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 35 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** Superparamagnetic Iron Oxide Magnetic Resonance Imaging

## Key facts

- **NCT ID:** NCT00920023
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2012-02
- **Final completion:** 2013-02
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2017-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00920023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00920023, "Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00920023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*